Regular Member 0 Current Trade Leads 0 Current Products | North China Pharmaceutical Group New Drug R&D Co., Ltd | |
|
|
Create your own company page now! |
|
North China Pharmaceutical Group New Drug R&D Co., Ltd |
North China Pharmaceutical Group New Drug Research and Development Co., Ltd (NCPC R&D) is a subsidiary of North China Pharmaceutical Group Corporation (NCPC). Aiming at the discovery of novel drugs, NCPC R&D focuses primarily on the research and development of biological products and pharmaceutical chemicals. We have already obtained cGMP in this line, and would like to provide you with the best products and services. We, NCPCR&D, as the original manufacturer of bulk pharmaceuticals and finish preparations in China, specilized in pharmaceutical chemicals and would like to introduce our main products to you. Immunosuppressant group: -cyclosporine A
-tacrolimus (FK506) -sirolimus (rapamycin) -mycophenolate mofetil / mycophenolate sodium
-mizoribine
-norvancomycin hydrochloride
-teicoplanin
-FK520
-Daptomycin
-norvacomycin Hcl
We are regularly Selling: cyclosporine, tacrolimus, sirolimus, mycophenolate mofetil, fk506, fk520, teicoplanin, daptomycin, mizoribine. |
|
|
www.TradeHolding.net Tip: We always strongly recommend our members to strictly follow the traditional methods and rules of international trading before going into any deal with any party met over the internet. Such as getting prior company confirmation by phone, fax or by mail besides necessary cross checks done through the related local bodies like banks, chambers of commerce, related trade associations, etc. especially before realizing any money transaction. |
Contact Person: |
Alice Xu |
Job Title: |
Manager |
Location: |
China - Hebei Companies from China Trade Leads from China Products from China |
Classification(s): | Health & Beauty - Drugs & Medications |
Primary Business Type(s): |
Manufacturer More Manufacturers... |
|
Contact Information |
Join Now or Login to contact North China Pharmaceutical Group New Drug R&D Co., Ltd! |
|
View More Companies |
|
|
|
|